Your browser doesn't support javascript.
loading
Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial.
Soulières, Denis; Faivre, Sandrine; Mesía, Ricard; Remenár, Éva; Li, Shau-Hsuan; Karpenko, Andrey; Dechaphunkul, Arunee; Ochsenreither, Sebastian; Kiss, Laura Anna; Lin, Jin-Ching; Nagarkar, Raj; Tamás, László; Kim, Sung-Bae; Erfán, Jozsef; Alyasova, Anna; Kasper, Stefan; Barone, Carlo; Turri, Sabine; Chakravartty, Arunava; Chol, Marie; Aimone, Paola; Hirawat, Samit; Licitra, Lisa.
Afiliação
  • Soulières D; Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.
  • Faivre S; Oncology Unit, Hôpitaux Universitaires Paris Nord Val de Seine, Paris, France.
  • Mesía R; Medical Oncology Department, Institut Català d'Oncologia L'Hospitalet, Barcelona, Spain.
  • Remenár É; Head, Neck and Jaw, Reconstructive Plastic Surgery and Laser Surgery Department, Országos Onkológiai Intézet, Budapest, Hungary.
  • Li SH; Department of Hematology-Oncology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
  • Karpenko A; Department of Oncology, Leningrad Regional Oncology Dispensary, Saint Petersburg, Russian Federation.
  • Dechaphunkul A; Department of Medicine, Prince of Songkla University, Songkhla, Thailand.
  • Ochsenreither S; Department of Hematology, Oncology and Tumor Immunology, Charité Comprehensive Cancer Center, Berlin, Germany.
  • Kiss LA; Department of Otorhinolaryngology, Szent Imre University Teaching Hospital, Budapest, Hungary.
  • Lin JC; Department of Radiation Oncology, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Nagarkar R; Department of Surgical Oncology, Curie Manavata Cancer Centre, Maharashtra, India.
  • Tamás L; Department of Otorhinolaryngology and Head and Neck Surgery, Semmelweis University, Budapest, Hungary.
  • Kim SB; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Erfán J; Radiation Oncology Department, Jósa András Teaching Hospital, Nyíregyháza, Hungary.
  • Alyasova A; Department of Oncology, Prevoljskiy Region Medical Centre, Novgorod, Russia.
  • Kasper S; West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Barone C; Medical Oncology Unit, Catholic University of the Sacred Heart, Rome, Italy.
  • Turri S; Oncology Global Development, Novartis Pharma SAS, Paris, France.
  • Chakravartty A; Oncology Biostatistics, Novartis Healthcare Private Limited, Hyderabad, India.
  • Chol M; Oncology Precision Medicine, Novartis Pharma AG, Basel, Switzerland.
  • Aimone P; Oncology Global Development, Novartis Pharma AG, Basel, Switzerland.
  • Hirawat S; Novartis Oncology, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Licitra L; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; University of Milan, Milan, Italy. Electronic address: lisa.licitra@istitutotumori.mi.it.
Lancet Oncol ; 18(3): 323-335, 2017 03.
Article em En | MEDLINE | ID: mdl-28131786
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Cabeça e Pescoço / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Cabeça e Pescoço / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Canadá